bf/NASDAQ:TGTX_icon.jpeg

COM:TGTHERAPEUTICS

TG Therapeutics Inc

  • Stock

Last Close

34.55

22/11 21:00

Market Cap

3.17B

Beta: -

Volume Today

2.57M

Avg: -

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocyti...Show More

peer of